Related Experiment Video
Updated: Mar 7, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
The Gut Microbiota in Inflammatory Bowel Disease
Donal Sheehan1, Fergus Shanahan1
1Department of Medicine, APC Microbiome Institute, University College Cork, National University of Ireland, Ireland.
Genes, bacteria, and immunity play roles in inflammatory bowel disease (IBD) pathogenesis. While microbiota manipulation in adulthood is uncertain, gut bacteria may indicate risk, influence disease activity, and contribute to IBD complications.
Area of Science:
- Immunology
- Microbiology
- Genetics
Background:
- Inflammatory bowel disease (IBD) pathogenesis involves complex interactions between host genetics, bacterial communities (microbiota), and immune system responses.
- Genetic predisposition to IBD often stems from impaired microbial sensing or dysregulated immune responses to gut bacteria.
- The gut microbiota's crucial role in immune system development, established early in life, raises questions about its therapeutic manipulation in adulthood.
Purpose of the Study:
- To explore the multifaceted roles of genes, bacteria, and immunity in inflammatory bowel disease (IBD).
- To evaluate the potential and limitations of targeting the gut microbiota for IBD treatment in adult patients.
- To understand the microbiota's contribution to disease risk, activity, and extraintestinal manifestations in IBD.
Main Methods:
- Review of existing literature on IBD pathogenesis, focusing on genetic factors, microbial composition, and immune mechanisms.
- Analysis of the temporal relationship between microbiota development, immune maturation, and disease onset.
- Examination of studies investigating the microbiota as a biomarker and therapeutic target in IBD.
Main Results:
- Genetic factors influencing IBD risk are linked to host-microbe interactions, including microbial metabolite sensing and immune regulation.
- The early-life establishment of the microbiota and its influence on immune programming suggest challenges for adult-onset microbiota-based therapies.
- The gut microbiota is implicated as a potential marker for IBD risk, a modulator of disease severity, and a contributor to associated conditions outside the gastrointestinal tract.
Conclusions:
- IBD is a complex disease influenced by host genetics, bacterial communities, and immune responses.
- Therapeutic manipulation of the adult microbiota for IBD may be limited due to its early-life programming of the immune system.
- The gut microbiota remains a significant factor in IBD, potentially serving as a risk indicator, disease modifier, and contributor to extraintestinal issues.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.

